182 - What’s New With Respiratory Infections in Children?

Tuesday, October 21, 2025

3:15 PM - 4:30 PM US ET

Location: B206

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Angela Campbell, MD, MPH, FPIDS, FIDSA

Adjunct Professor of Pediatrics
Emory University School of Medicine
Asuncion Mejias, MD, PhD, MsCS (she/her/hers)

Member, St Jude Faculty
Pediatrics, Infectious Diseases
St Jude Children's Research Hospital
Memphis, TN, United States

Faculty(s)

AH

Adam Hersh, MD PhD

Pediatric Infectious Diseases Physician
Pediatric Infectious Diseases
University of Utah
Salt Lake City, UT, United States
Kristen Wendorf, MD, MS (she/her/hers)

Public Health Medical Officer
California Department of Public Health, TB Control; University of California, San Francisco; Curry International TB Center
Piedmont, CA, United States
Octavio Ramilo, MD

Chair, Department of Infectious Diseases
Infectious Diseases
St. Jude Children's Research Hospital
Memphis, TN, United States

Disclosure(s):

Angela Campbell, MD, MPH, FPIDS, FIDSA: No financial relationships to disclose.

Asuncion Mejias, MD, PhD, MsCS: No financial relationships to disclose.

Adam Hersh, MD PhD: No financial relationships to disclose.

Kristen Wendorf, MD, MS: No financial relationships to disclose.

Octavio Ramilo, MD: Gates Foundation: Grant/Research Support; Merck, Sharpe & Dohme: Advisor/Consultant, Grant/Research Support, Honoraria; Moderna: Advisor/Consultant; NIH/NIAID: Board Member, Grant/Research Support; Pfizer, Inc.: Advisor/Consultant, Honoraria; Sanofi Pasteur LLC: Advisor/Consultant, Honoraria

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe updates on epidemiology, diagnosis, treatment and prevention of MDR TB in children;
discuss the latest epidemiology and challenges related to respiratory bacteria (including mycoplasma, pertussis, and more);
explain the immune mechanisms associated with RSV disease protection or severity in infants, toddlers, and young children.

Presentations:

3:15 PM - 3:40 PM US ET

Not The Same Old TB: Updates on Pediatric Multidrug-Resistant Tuberculosis
Speaker: Kristen Wendorf, MD, MS (she/her/hers) – California Department of Public Health, TB Control; University of California, San Francisco; Curry International TB Center
3:40 PM - 4:05 PM US ET

Hot Topics in Respiratory Bacteria
Speaker: Adam Hersh, MD PhD – University of Utah
4:05 PM - 4:30 PM US ET

RSV Infections and the Immune System: Implications in the Era of RSV Prevention
Speaker: Octavio Ramilo, MD – St. Jude Children's Research Hospital